Stroke

赵志刚 / Wang YongjunPeople's Medical Publishing House · ChinaJan 2025

Rating 3.4
Word count
177K words
Chapters
82
ISBN
9787117232180

Tags

Medicine Expert EditorsClinical PharmacyHealth PromotionSafe MedicationHome Health CarePatient EducationMedication GuidanceDisease PreventionCommunity CareMedical Science

Summary

This book is one of the "Safe Medication Project"—Community Safe Medication Guidance series, jointly initiated and planned by the China Health Promotion Foundation, the Beijing Pharmacists Association, and the Department of Pharmacy of Beijing Tiantan Hospital, Capital Medical University. It is co-edited by Professor Wang Yongjun, a national cerebrovascular disease expert at Beijing Tiantan Hospital and vice president of the Chinese Stroke Association, and Professor Zhao Zhigang, a pharmaceutical expert and director of the Department of Clinical Pharmacy at Capital Medical University, with contributions from renowned frontline neurologists and clinical pharmacy experts in Beijing. It describes in detail the essential knowledge of stroke prevention and treatment from four aspects: disease progression, diagnosis and treatment, pharmacotherapy, and preventive care. In particular, it integrates extensive practical experience from pharmaceutical and clinical experts, using comparative tables to describe in detail the indications, contraindications, pharmacokinetic parameters, adverse reactions, and interactions of commonly used clinical drugs for stroke, making it easy for community medical staff to compare and select medications.

Editor's review

This is a practical guide to stroke prevention and treatment for community settings, co-written by experts in neurology and clinical pharmacy. Its defining feature is that it integrates two threads—diagnosis and treatment, and medication—into one volume. Beyond covering disease progression, prevention, and health care, the book uses comparative tables to lay out in detail the indications, contraindications, pharmacokinetic parameters, adverse reactions, and interactions of commonly used clinical drugs, so that community health workers can quickly compare and choose among them in practice. Compared with patient-facing popular science books, this one is closer to the decision-making needs of primary care, and the incorporation of pharmacy practice insights keeps the content from staying at the theoretical level. When reading, it is advisable to keep the drug comparison tables at hand as a tool for quick reference, while the diagnosis and treatment sections are suited to systematic reading to build an overall framework. For community doctors and pharmacists who need to manage medication issues in stroke patients, this is a reference book to keep close by and consult repeatedly.

Who it's for

A good fit for

Not a good fit for

Reading tips

  1. First read through the disease progression and diagnosis/treatment sections to build a framework, then keep the drug comparison tables at hand as a tool for quick reference.
  2. Use real community cases to check the book's lists of drug indications and contraindications, reinforcing retention.
  3. Focus on the adverse reactions and interactions sections, and compile them into medication reminder cards suited to your own institution.
  4. Read alongside other volumes in the series to form a complete knowledge structure for safe medication in the community.

About the publisher

People's Medical Publishing House China · Founded in 1953

Founded in 1953, the People's Medical Publishing House is an important institution in China's medical publishing field, with publishing directions covering medical textbooks, academic monographs, medical journals, and popular science books. Its collection contains 2,503 titles, mainly classified under medicine. Representative works include the Complete Book of Chinese Nutrition Science (2nd Edition, 2 volumes), Guide to Clinical Practice with Medical Records, the Golden Mirror of Medicine (Volume 1), Chinese Medical Imaging: Head and Neck Volume (3rd Edition), and the Essentials of the Golden Cabinet from the Collected Clinical Chinese Medicine Must-Read Series (Collector's Edition), spanning both modern medicine and classical Chinese medical texts. Representative authors include Yang Yuexin, Ge Keyou, Ye Tianshi, Su Li, Wu Qian, Zheng Jinsheng, Wang Zhenchang, and Xian Junfang, covering fields such as nutrition, Chinese medicine, and medical imaging. With a publishing approach that balances textbooks and academic monographs, the press has established the "Renwei" brand.

Contents

  1. 版权信息
  2. 序
  3. 前言
  4. 第一章 脑卒中的流行病学
  5. 第一节 脑卒中的病因及危险因素
  6. 第二节 脑卒中的风险预测
  7. 第二章 缺血性脑卒中
  8. 第一节 短暂性脑缺血发作
  9. 第二节 大动脉粥样硬化性卒中
  10. 第三节 腔隙性脑梗死/小动脉闭塞性卒中
  11. 第四节 心源性脑栓塞
  12. 第五节 出血性脑梗死
  13. 第六节 其他原因引发的缺血性卒中
  14. 第三章 其他类型脑卒中
  15. 第一节 脑出血
  16. 第二节 蛛网膜下腔出血
  17. 第三节 颅内静脉系统血栓形成
  18. 第四章 脑卒中的并发症
  19. 第一节 脑水肿与脑疝
  20. 第二节 深静脉血栓
  21. 第三节 卒中相关性肺炎
  22. 第四节 糖代谢异常
  23. 第五节 营养不良
  24. 第六节 压疮
  25. 第七节 应激性溃疡
  26. 第八节 脑心综合征
  27. 第九节 脑卒中后抑郁障碍
  28. 第十节 脑卒中后癫痫
  29. 第五章 缺血性脑卒中的急性期治疗
  30. 第一节 静脉溶栓
  31. 第二节 抗血小板
  32. 第三节 抗凝
  33. 第四节 调脂
  34. 第五节 降压
  35. 第六节 降纤
  36. 第七节 扩容
  37. 第八节 手术
  38. 第九节 介入（动脉溶栓、成形术、支架、取栓）
  39. 第十节 脑保护
  40. 第六章 其他类型脑卒中的急性期治疗
  41. 第一节 概述
  42. 第二节 蛛网膜下腔出血
  43. 第三节 颅内静脉系统血栓形成
  44. 第七章 脑卒中的并发症治疗
  45. 第一节 脑水肿与脑疝
  46. 第二节 深静脉血栓
  47. 第三节 卒中相关性肺炎
  48. 第四节 糖代谢异常
  49. 第五节 营养不良
  50. 第六节 压疮
  51. 第七节 应激性溃疡
  52. 第八节 脑心综合征
  53. 第九节 脑卒中后抑郁障碍
  54. 第十节 脑卒中后癫痫
  55. 第八章 脑卒中的预防
  56. 第一节 一级预防
  57. 第二节 二级预防
  58. 第九章 脑卒中的康复治疗
  59. 第一节 康复治疗的原则
  60. 第二节 运动障碍的评价与康复
  61. 第三节 感觉障碍的评价与康复
  62. 第四节 吞咽障碍的评价与康复
  63. 第五节 失认症的评价与康复
  64. 第六节 失语的康复评价与治疗
  65. 第七节 日常生活活动能力障碍的评价与康复
  66. 第八节 常见并发症的康复治疗
  67. 第十章 脑卒中治疗药物
  68. 第一节 降压治疗药物
  69. 第二节 降糖治疗药物
  70. 第三节 降脂治疗药物
  71. 第四节 抗血小板药物
  72. 第五节 抗凝和降纤药物
  73. 第六节 脑微循环治疗药物
  74. 第七节 脑保护治疗药物
  75. 第十一章 常见用药问题解答
  76. 一、抗血小板用药相关问题
  77. 二、降脂用药相关问题
  78. 三、抗凝溶栓用药相关问题
  79. 四、精神用药相关问题
  80. 五、降压用药相关问题
  81. 六、中药相关问题
  82. 七、其他

FAQ

Is this book suitable for ordinary patients and family members? Not really. This book is aimed at community health workers and covers professional information such as drug indications, pharmacokinetic parameters, and interactions, which readers without a medical background will find difficult to understand. Family members are better served by public-facing popular science books on stroke.
What practical value do the drug comparison tables in the book have? The book uses comparative tables to describe in detail the indications, contraindications, pharmacokinetic parameters, adverse reactions, and interactions of commonly used clinical drugs, making it easy for community health workers to quickly compare and choose medications in clinical work and reducing the time spent consulting multiple references.
Which book series does this book belong to? This book is one of the "Safe Medication Project"—"Community Safe Medication Guidance" series, jointly planned by the China Health Promotion Foundation, the Beijing Pharmacists Association, and the Department of Pharmacy of Beijing Tiantan Hospital, Capital Medical University, and is positioned as safe medication guidance for community health workers.
Is it difficult for community doctors who are not neurologists to read? There is a certain professional threshold, but the overall arrangement takes community settings into account. The diagnosis and treatment sections are systematic and clear, and the drug sections are presented in comparison tables for easy reference. It is advisable to first read through the disease progression framework, then use the drug tables as a tool, learning by checking them against everyday cases and gradually becoming familiar.

Related on WeRead

脑卒中：与时间赛跑 谢青 顾琳 脑卒中 赵志刚 王拥军主编 名医与您谈疾病丛书：脑卒中（第2版） 李广智 陈生弟 宋永建 等 脑卒中宝典（猫大夫医学科普） 缪中荣 脑卒中居家照护指导手册 常红 宋海庆

This site is an index: you start “Search all sources” in your browser, and the entries it lists all point to third-party sites; please judge their availability yourself.

About the author

赵志刚 Author

Zhao Zhigang is an author in the fields of medicine and popular science. Public information about him is limited, and his research and writing focus mainly on clinical medication safety and medication counseling. Five of his works are included in the collection: the Standardized Medication Counseling Manual series volume on smoking cessation management, the volume on cerebrovascular disease, Making Medication Safer, a Guide to Anti-infective Treatment in Emergency Care, and Stroke. These works are largely oriented toward clinical practice and public medication education, emphasizing standardized procedures for medication counseling while also addressing specialist settings such as emergency anti-infective treatment and common health topics including smoking cessation, cerebrovascular disease, and stroke. The writing is practical and operational in style, presented as manuals and popular-science readers that are convenient for medical staff and general readers to consult, and it offers practical value in medication safety and science communication.

Wang Yongjun Author · Chinese · 1962

Wang Yongjun, born in September 1962 in Handan, Hebei, is a neurologist and an academician of the Chinese Academy of Sciences, currently serving as president of Beijing Tiantan Hospital, Capital Medical University. He has long been engaged in clinical and translational research on cerebrovascular diseases, pioneered a dual-channel antiplatelet therapy for ischemic cerebrovascular disease, and helped extend the time window for intravenous thrombolysis. He has edited and translated several medical works, including Vascular Neurology and the Tiantan Clinical Trial Manual. The library holds 17 of his works, mainly medical titles on diagnostic and treatment standards for neurological diseases, panvascular medicine and advances in neurology, alongside topics in traditional Chinese medicine such as the "kidney governs bone" theory, as well as biographies and management books.